| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xencor, Inc. (XNCR) has 8 insiders with recent SEC Form 4 filings, including 2 buys and 11 sells. XNCR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 477.3K | $6.69M | - | |
| VP | 242.9K | $3.40M | - | |
| Dir | 110.4K | $1.55M | - | |
| CFO | 75.9K | $1.06M | - | |
| Dir | 15.5K | $217.8K | -5,064 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 28, 2017 | Stafford John S III | 10% Owner | Buy | 6,000 | $19.94 | $119,640.00 | +0.1% | |
| Jun 16, 2017 | Stafford John S III | 10% Owner | Buy | 1,500 | $19.67 | $29,509.95 | - | |
| Jun 14, 2017 | Carter Bruce L A | Director | Sell | 20,000 | $20.61 | $412,237.53 | -17.0% | |
| Jun 2, 2017 | Carter Bruce L A | Director | Sell | 2,366 | $22.00 | $52,052.00 | -3.3% | |
| May 26, 2017 | Carter Bruce L A | Director | Sale+OE | 12,400 | $22.19 | $275,212.69 | -8.0% | |
| May 2, 2017 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 10,568 | $26.01 | $274,917.18 | -100% | |
| Apr 27, 2017 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 904 | $26.04 | $23,540.07 | -100% | |
| Mar 16, 2017 | Kuch John J68 | Vice President, Finance | Sale+OE | 15,000 | $24.42 | $366,277.50 | -16.3% | |
| Mar 15, 2017 | Desjarlais John R76 | Sr. V.p., Research &CSO | Sell | 13,755 | $24.47 | $336,637.12 | -13.5% | |
| Mar 8, 2017 | Baracchini Edgardo Jr | Chief Business Officer | Sale+OE | 1,821 | $25.00 | $45,525.00 | -100% |